Wednesday, March 17, 2010

ARNA 4th quarter earnings

Arena Pharmaceuticals Inc (ARNA.O) expects to launch sales of its weight loss drug -- alone or with a partner -- within 12 weeks of U.S. regulatory approval, according to the company.

Shares are up 10% today.

Disclosure: long ARNA shares.

No comments:

Post a Comment